Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Jun 7;44(3):0.
doi: 10.1590/S1806-37562018000030001. Online ahead of print.

The importance of the World Symposium on Pulmonary Hypertension

[Article in English, Portuguese]
Carlos Jardim  1 , Daniel Waetge  2
Affiliations
Editorial

The importance of the World Symposium on Pulmonary Hypertension

[Article in English, Portuguese]
Carlos Jardim et al. J Bras Pneumol. .
No abstract available

PubMed Disclaimer

References

    1. Gurtner HP. Aminorex and pulmonary hypertension A review. Cor Vasa. 1985;27(2-3):160–171. - PubMed
    1. D'Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM. Survival in patients with primary pulmonary hypertension Results from a national prospective registry. Ann Intern Med. 1991;115(5):343–349. doi: 10.7326/0003-4819-115-5-343. - DOI - PubMed
    1. Barst RJ, Rubin LJ, Long WA, McGoon MD, Rich S, Badesch DB. A comparison of continuous intravenous epoprostenol with conventional therapy for primary pulmonary hypertension. N Engl J Med. 1996;334(5):296–301. doi: 10.1056/NEJM199602013340504. - DOI - PubMed
    1. Simonneau G, Galiè N, Rubin LJ, Langleben D, Seeger W, Domenighetti G. Clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2004;43(12 Suppl S):5S–12S. doi: 10.1016/j.jacc.2004.02.037. - DOI - PubMed
    1. Rubin LJ, Badesch DB, Barst RJ, Galie N, Black CM, Keogh A. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med. 2002;346(12):896–903. doi: 10.1056/NEJMoa012212. - DOI - PubMed

Publication types